Baker Chad R Bristol Myers Squibb CO Transaction History

Baker Chad R

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $1.17 Million - $1.46 Million	-23,200 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $80,919 - $88,222	1,350 Added 6.18%	23,200 $1.42 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,850	21,850 $1.22 Million

2,404

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Baker Chad R, based on Form 13F filings with the SEC.

Stay updated on Baker Chad R with notifications on news.